Mar 12, 2003
HEMISPHERX ACQUIRES RIGHTS FOR THE ONLY FDA APPROVED NATURAL ALPHA INTERFERON DRUG Company Completes a $5,500,000 Private Placement Conference Call to be Held On Tuesday, March 18, 2003 at 11:00am EST

Mar 06, 2003
Hemispherx Biopharma to Present New Interim Clinical Data Regarding Phase IIB Study in HIV/AIDS at the 16th International Conference on Antiviral Research

Feb 12, 2003
Expanded Clinical Data on AmpligenÒ in HIV Disease to be presented at the 16th International Conference on Antiviral Research

Jan 31, 2003
Hemispherx Presents New Data on Long-term, Post-trial Effects of RNA-based Ampligen(R) for Treatment for Chronic Fatigue Syndrome

Jan 24, 2003
HEMISPHERX ANNOUNCES TAGLICH BROTHERS RELEASE OF UPDATED RESEARCH REPORT

Jan 22, 2003
REBROADCAST OF HEMISPHERX'S JANUARY 21, 2003 CONFERENCE CALL AVAILABLE ON COMPANY'S WEBSITE OR VIA TELEPHONE REPLAY

Jan 17, 2003
HEMISPHERX SCHEDULES CONFERENCE CALL TO REVIEW RECENT DEVELOPMENTS IN CLINICAL TRIAL EXPANSION, STRATEGIC PARTNERSHIP SUPPORT, FUNDING AND THE OVERALL COMMERCIALIZATION PROCESS

Jan 15, 2003
OFFUTT SECURITIES UPDATES INDEPENDENT RESEARCH COVERAGE ON HEMISPHERX BIOPHARMA, INC.

Jan 15, 2003
HEMISPHERX FILES WITH REGULATORS TO REGISTER 5 MILLION SHARES OF STOCK TO SUPPORT CLINICAL TRIAL EXPANSION

Jan 15, 2003
Hemispherx Biopharma's International Team of Clinical Researchers to Present New Data on Experimental Treatment of CFS

 63   64   65   66   67     68    69   70   71   72   73